Targeted Oncology10d
Experts Discuss Tislelizumab’s FDA Approval in Esophageal Cancer
Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for ...
Baylor College of Medicine4y
Esophageal Cancer
The most common types of esophageal cancer are squamous cell carcinoma and adenocarcinoma. The American Cancer Society’s estimates about 16,940 new esophageal cancer cases diagnosed (13,360 in men and ...
MedPage Today on MSN4d
Active Surveillance May Have a Role in Esophageal Cancer
Active surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...
Targeted Oncology9d
Kato Breaks Down FDA Approval of Tislelizumab in Esophageal Cancer
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Business Wire19d
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy
“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell carcinoma marks a significant step forward in tackling the unmet needs in this challenging disease are ...